Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 84, Issue 2, 2008, Pages 415-421

  Anitua, Eduardo ^a   Aguirre, José J ^a   Algorta, Jaime ^b   Ayerdi, Eduardo ^b   Cabezas, Ana I ^b   Orive, Gorka ^a   Andia, Isabel ^a  

^a Biotechnology Institute   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

Author keywords

Chronic cutaneous ulcers; Growth factors; Platelet; PRGF; Randomized trial

Indexed keywords

BIOMATERIALS; GROWTH KINETICS; TISSUE;

CHRONIC CUTANEOUS ULCERS; RANDOMIZED TRIAL; THERAPEUTIC STRATEGY;

PLATELETS;

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PLASMA; RANDOMIZED CONTROLLED TRIAL; SKIN ULCER; THROMBOCYTE; TISSUE REGENERATION; TREATMENT INDICATION; TREATMENT OUTCOME; WOUND CARE; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION, AUTOLOGOUS; CHRONIC DISEASE; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET TRANSFUSION; SKIN ULCER; WOUND HEALING;

EID: 38349185627     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30886     Document Type: Article

References (32)

1. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology 1997;48:67-69.
2. Diegelman RF, Evans MC. Wound healing: An overview of acute fibrotic and delayed healing. Front Biosci 2004;9:283-289.
3. Carter CA, Jolly DG, Worden CE Sr, Hendren DG, Kane CJM. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 2003;74:244-255.
4. Yager DR, Zhang LY, Liang HX, Diegelman RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107:743-748.
5. Mwaura B, Mehendran B, Hynes N, Defreitas D, Avalos G, Adegbola T, Adham M, Connolly CE, Sultan S. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Eur J Endovasc Surg 2006;31:306-310.
6. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004;91:4-15.
7. Bennett NT, Schultz GS. Growth factors and wound healing: Biochemical properties of growth factors and their receptors. Am J Surg 1993;166:74-81.
8. Bennett NT, Schultz GS. Growth factors and wound healing. Part II. Role in normal and chronic wound healing. Am J Surg 1993;165:728-737.
9. Pu X, Li X, Cheng B, Chen W, Sheng Z. Engineered growth factors and cutaneous wound healing: Success and possible questions in the past 10 years. Wound Rep Regen 2005;13:122-130.
10. Goldman R. Growth factors and chronic wound healing: Past, present, and future. Avd Skin Wound Care 2004;17:24-35.
11. Knighton DR, Doucette M, Fiegel VD, Ciresi K, Butler E, Austin L. The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res 1988;266:319-329.
12. Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: A preliminary report. J Vasc Surg 1991;14:526-532.
13. Ganio C, Tenewitz FE, Wilson RC, Moyles BG. The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors. J Foot Ankle Surg 1993;32:263-268.
14. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Moroni M, Carabelli A. Platelet gel for healing cutaneous chronic wounds. Transf Apheresis Sci 2004;30:145-151.
15. Saldalamacchia G, Lapice E, Cuomo V, De Feo E, D'Agostino E, Rivellese AA, Vaccaro O. A controlled study of the use of autologous platelet gel for the treatment of diabetic ulcers. Nutr Metab Cardiovasc Dis 2004;14:395-396.
16. Stacey MC, Mata SD, Trengove NJ, Mather CA. Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 2000;20:296-301.
17. Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006;5:227-234.
18. Anitua E. Plasma rich in growth factors: Preliminary results of the use in the preparation of future sites for implants. Int J Oral Maxillofac Impl 1999;14:529-535.
19. Anitua E, Andia I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, Nurden P, Nurden AT. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23:281-286.
20. Anitua E, Sanchez M, Nurden AT, Zalduendo M, de la Fuente M, Orive G, Azofra J, Andia I. Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities. J Biomed Mat Res 2006;77:285-293.
21. Sánchez M, Azofra J, Anitua E, Andia I, Padilla S, Santisteban J, Mujika I. Plasma rich in growth factors to treat an articular cartilage avulsion: A case report. Med Sci Sports Exerc 2003;35:1648-1652.
22. Stotts NA, Rodeheaver GT, Thomas DR, Frantz RA, Bartolucci AA, Sussman C, Ferrell BA, Cuddigan J, Maklebust J. An instrument to measure healing in pressure ulcers: Development and validation of the pressure ulcer scale for healing (PUSH). J Gerontol A Biol Sci Med Sci 2001;56:M795-M799.
23. Taylor RJ. Mouseyes revisited: Upgrading a computer program that aids wound measurement. J Wound Care 2002;11:213-216.
24. Araujo T de, Valencia I, Kirsner RS. Managing the patient with venous ulcers. Ann Intern Med 2003;138:326-334.
25. Margolis DJ, Bartus C, Hoffstad O, Malay S, Berlin JA. Effectiveness of recombinant human platelet-derived growth factors for treatment of diabetic neuropathic foot ulcers. Wound Rep Regen 2005;13:531-536.
26. Clark RA. Regulation of fibroplasias in cutaneous wound repair. Am J Med Sci 1993;306:42-48.
27. Bitar MS. Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds. Surgery 2000;127:687-695.
28. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870.
29. Martí-Mestre FX, Acosta-Gómez M, Bonell-Pascual A, Linares-Ruiz P, Romera C. Yñiguez-Navas O. Resultados preliminares de la aplicación de factores de crecimiento en el tratamiento de las úlcéras vasculares. Angiologia 2005;57:335-343.
30. Mazzucco L, Medici D, Serna M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P. The use of autologous platelet gel to treat difficult to heal wounds: A pilot study. Transfusion 2004;44:1013-1018.
31. Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on periimplant bone regeneration. Bone 2004;34:665-671.
32. Drew AF, Liu JM, Davidson JM, Daugherty CC, Degen JL. Wound healing defects in mice lacking fibrinogen. Blood 2001;97:3691-3698.